The Electron Post
@electronpost.bsky.social
This newsletter offers comprehensive coverage of the latest developments, trends, and innovations in the chemical and pharmaceutical industries and related engineering disciplines. https://electronpost.wordpress.com/
Vertex announced that Suzetrigine (Journavx), a non-opioid oral pain signal inhibitor, has been approved for medical use. cutt.ly/4e6QXsHV
February 10, 2025 at 2:18 PM
Vertex announced that Suzetrigine (Journavx), a non-opioid oral pain signal inhibitor, has been approved for medical use. cutt.ly/4e6QXsHV